Jane Wang
Direttore Tecnico/Scientifico/R&S presso APOLLOMICS, INC.
Profilo
Jane Wang currently works at Apollomics, Inc. (United States), as Chief Scientific Officer and Apollomics, Inc., as Chief Scientific Officer from 2023.
Dr. Wang also formerly worked at Pfizer Inc., as Principal and WuXi AppTec Co., Ltd., as Vice President-Medicinal Chemistry from 2010 to 2022.
Dr. Wang received her doctorate degree from the University of Maryland and undergraduate degree from Fudan University.
Posizioni attive di Jane Wang
| Società | Posizione | Inizio |
|---|---|---|
| APOLLOMICS, INC. | Direttore Tecnico/Scientifico/R&S | 30/03/2023 |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Jane Wang
| Società | Posizione | Fine |
|---|---|---|
| WUXI APPTEC CO., LTD. | Corporate Officer/Principal | 01/07/2022 |
| PFIZER, INC. | Corporate Officer/Principal | - |
Formazione di Jane Wang
| Fudan University | Undergraduate Degree |
| University of Maryland | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| APOLLOMICS, INC. | Health Technology |
| WUXI APPTEC CO., LTD. | Health Technology |
| PFIZER, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Apollomics, Inc. (United States)
Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Health Technology |
- Borsa valori
- Insiders
- Jane Wang